Next Article in Journal
SNEDDS Containing Poorly Water Soluble Cinnarizine; Development and in Vitro Characterization of Dispersion, Digestion and Solubilization
Next Article in Special Issue
Safety Monitoring in Clinical Trials
Previous Article in Journal
Composition Influence on Pulmonary Delivery of Rifampicin Liposomes
Previous Article in Special Issue
Quantitative Evaluation of Compliance with Recommendation for Sulfonylurea Dose Co-Administered with DPP-4 Inhibitors in Japan
Pharmaceutics 2012, 4(4), 607-640; doi:10.3390/pharmaceutics4040607

Notes on Article Versions

article html file updated24 January 2013 11:01 CET
article html file updated7 February 2013 17:24 CET
Article Edited21 February 2013 13:52 CET
Article Edited22 February 2013 09:07 CET
article xml file uploaded13 September 2013 17:19 CEST
article html file updated13 September 2013 17:19 CEST
article html file updated17 June 2015 04:47 CEST
Pharmaceutics EISSN 1999-4923 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert